MDMA therapy for PTSD voted down by FDA advisory panel
				In a surprisingly strong rejection of the first psychedelic therapy to come before the Food and Drug Administration, a scientific advisory panel on Tuesday overwhelmingly voted against the use of MDMA for treating PTSD, putting its…					
Read More...
				Read More...